Form 4: Ingevity Director Karen Narwold Receives Stock Grant

Ingevity Corporation director Karen G. Narwold was granted 1,904 restricted stock units as part of the company's 2025 Omnibus Incentive Plan.

Summary

• Director Karen G. Narwold acquired 1,904 shares of Ingevity Corporation (NGVT) common stock.
• The acquisition was in the form of a restricted stock unit (RSU) grant.
• The transaction occurred on April 30, 2026.
• Following this transaction, the director's total beneficial ownership is 18,900 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine regulatory disclosure regarding director compensation with no material impact on the company's financial outlook.

Positives

• The grant aligns the director's interests with those of shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• The value of the granted equity is subject to market volatility and the future performance of Ingevity Corporation.

Future Outlook

The restricted stock units are scheduled to vest in full on April 30, 2027, subject to the terms of the 2025 Omnibus Incentive Plan.

Industry Context

StockSavvy.ai notes that equity grants to board members are standard corporate governance practice to ensure long-term alignment between leadership and shareholder interests.

Comparison to Industry Standards

• The use of restricted stock units for director compensation is consistent with standard practices for mid-cap industrial companies.
• The vesting period of one year is a common retention and incentive structure for board members.

Stakeholder Impact

• Shareholders may view the equity grant as a standard alignment of director incentives.

Next Steps

• Vesting of the 1,904 restricted stock units on April 30, 2027.

Key Dates

Keywords

Ingevity, NGVT, Form 4, Insider Trading, Director Compensation, Restricted Stock Units